{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T21:28:17Z","timestamp":1785878897980,"version":"3.56.0"},"reference-count":74,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T00:00:00Z","timestamp":1730937600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001823","name":"Ministerstvo \u0160kolstv\u00ed, Ml\u00e1de\u017ee a T\u011blov\u00fdchovy","doi-asserted-by":"publisher","award":["LM2023050"],"award-info":[{"award-number":["LM2023050"]}],"id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001823","name":"Ministerstvo \u0160kolstv\u00ed, Ml\u00e1de\u017ee a T\u011blov\u00fdchovy","doi-asserted-by":"publisher","award":["SVV 260519\/2023"],"award-info":[{"award-number":["SVV 260519\/2023"]}],"id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001823","name":"Ministerstvo \u0160kolstv\u00ed, Ml\u00e1de\u017ee a T\u011blov\u00fdchovy","doi-asserted-by":"publisher","award":["MSMT-37957\/2020-3"],"award-info":[{"award-number":["MSMT-37957\/2020-3"]}],"id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004240","name":"Akademie V\u011bd \u010cesk\u00e9 Republiky","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004240","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021704","name":"Czech Centre for Phenogenomics, Institute of Molecular Genetics of the Czech Academy of Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021704","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016366","name":"V\u0161eobecn\u00e1 Fakultn\u00ed Nemocnice v Praze","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016366","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006192","name":"Advanced Scientific Computing Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006192","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007397","name":"Univerzita Karlova v Praze","doi-asserted-by":"publisher","award":["NU22-05-00374"],"award-info":[{"award-number":["NU22-05-00374"]}],"id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007397","name":"Univerzita Karlova v Praze","doi-asserted-by":"publisher","award":["24-10353S"],"award-info":[{"award-number":["24-10353S"]}],"id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007397","name":"Univerzita Karlova v Praze","doi-asserted-by":"publisher","award":["24-10435S"],"award-info":[{"award-number":["24-10435S"]}],"id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007397","name":"Univerzita Karlova v Praze","doi-asserted-by":"publisher","award":["NU21-08-00312"],"award-info":[{"award-number":["NU21-08-00312"]}],"id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007397","name":"Univerzita Karlova v Praze","doi-asserted-by":"publisher","award":["START\/MED\/089"],"award-info":[{"award-number":["START\/MED\/089"]}],"id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007397","name":"Univerzita Karlova v Praze","doi-asserted-by":"publisher","award":["PRIMUS\/17\/MED\/16"],"award-info":[{"award-number":["PRIMUS\/17\/MED\/16"]}],"id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["00064165"],"award-info":[{"award-number":["00064165"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008667","name":"National Cancer Research Institute","doi-asserted-by":"publisher","award":["LX22NPO5102"],"award-info":[{"award-number":["LX22NPO5102"]}],"id":[{"id":"10.13039\/100008667","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Medical Research"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.arcmed.2024.103124","type":"journal-article","created":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T18:20:59Z","timestamp":1732558859000},"page":"103124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Deficiency of miR-155 in Leukemic B-Cells Results in Cell Cycle Arrest and Deregulation of MIR155HG\/TP53INP1\/CDKN1A\/CCND1 network"],"prefix":"10.1016","volume":"56","author":[{"given":"Elena","family":"Golovina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juraj","family":"Kokavec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitry","family":"Kazantsev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oxana","family":"Yurikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Bajecny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4889-837X","authenticated-orcid":false,"given":"Filipp Georgijevic","family":"Savvulidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4481-6680","authenticated-orcid":false,"given":"Radim","family":"Simersky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7387-0056","authenticated-orcid":false,"given":"Rene","family":"Lenobel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2683-0817","authenticated-orcid":false,"given":"Jorg","family":"Tost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1775-2394","authenticated-orcid":false,"given":"Vit","family":"Herynek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludek","family":"Sefc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9835-1375","authenticated-orcid":false,"given":"Marek","family":"Sebela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7786-9378","authenticated-orcid":false,"given":"Pavel","family":"Klener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7538-6601","authenticated-orcid":false,"given":"Zuzana","family":"Zemanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Stopka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4969-4133","authenticated-orcid":false,"given":"Karina Savvulidi","family":"Vargova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcmed.2024.103124_bib0001","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.tcb.2021.07.001","article-title":"Cell cycle on the crossroad of tumorigenesis and cancer therapy","volume":"32","author":"Liu","year":"2022","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.arcmed.2024.103124_bib0002","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1146\/annurev-biochem-060308-103103","article-title":"Regulation of mRNA translation and stability by microRNAs","volume":"79","author":"Fabian","year":"2010","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.arcmed.2024.103124_bib0003","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.608975","article-title":"The role of non-coding RNAs in controlling cell cycle related proteins in cancer cells","volume":"10","author":"Ghafouri-Fard","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.arcmed.2024.103124_bib0004","doi-asserted-by":"crossref","first-page":"15524","DOI":"10.1073\/pnas.242606799","article-title":"Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia","volume":"99","author":"Calin","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.arcmed.2024.103124_bib0005","doi-asserted-by":"crossref","first-page":"e585","DOI":"10.1038\/bcj.2017.63","article-title":"MiR-155\/miR-150 network regulates progression through the disease phases of chronic lymphocytic leukemia","volume":"7","author":"Vargova","year":"2017","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.arcmed.2024.103124_bib0006","doi-asserted-by":"crossref","first-page":"593","DOI":"10.3390\/cancers13040593","article-title":"MicroRNAs: tiny regulators of gene expression with pivotal roles in normal B-Cell development and B-Cell chronic lymphocytic leukemia","volume":"13","author":"Katsaraki","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.arcmed.2024.103124_bib0007","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.bbadis.2009.02.013","article-title":"miR-155 gene: a typical multifunctional microRNA","volume":"1792","author":"Faraoni","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.arcmed.2024.103124_bib0008","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/leu.2014.351","article-title":"MicroRNAs in B-cell lymphomas: how a complex biology gets more complex","volume":"29","author":"Musilova","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.arcmed.2024.103124_bib0009","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1126\/science.1139253","article-title":"Requirement of bic\/microRNA-155 for normal immune function","volume":"316","author":"Rodriguez","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.arcmed.2024.103124_bib0010","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1182\/blood-2013-01-478222","article-title":"Prognostic value of miR-155 in individuals with monoclonal B-cell lymphocytosis and patients with B chronic lymphocytic leukemia","volume":"122","author":"Ferrajoli","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.arcmed.2024.103124_bib0011","doi-asserted-by":"crossref","first-page":"E1695","DOI":"10.1073\/pnas.1201516109","article-title":"Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma","volume":"109","author":"Babar","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.arcmed.2024.103124_bib0012","doi-asserted-by":"crossref","first-page":"6982","DOI":"10.1073\/pnas.1002472107","article-title":"Modulation of mismatch repair and genomic stability by miR-155","volume":"107","author":"Valeri","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.arcmed.2024.103124_bib0013","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1126\/science.1141229","article-title":"Regulation of the germinal center response by microRNA-155","volume":"316","author":"Thai","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.arcmed.2024.103124_bib0014","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.immuni.2007.10.009","article-title":"microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells","volume":"27","author":"Vigorito","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.arcmed.2024.103124_bib0015","doi-asserted-by":"crossref","first-page":"7024","DOI":"10.1073\/pnas.0602266103","article-title":"Pre-B cell proliferation and lymphoblastic leukemia\/high-grade lymphoma in E(mu)-miR155 transgenic mice","volume":"103","author":"Costinean","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.arcmed.2024.103124_bib0016","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1080\/10428194.2018.1563692","article-title":"Evaluation of exosomal miR-155, let-7 g and let-7i levels as a potential noninvasive biomarker among refractory\/relapsed patients, responsive patients and patients receiving R-CHOP","volume":"60","author":"Zare","year":"2019","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.arcmed.2024.103124_bib0017","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s13402-016-0300-x","article-title":"MicroRNA-155 in serum-derived extracellular vesicles as a potential biomarker for hematologic malignancies - a short report","volume":"40","author":"Caivano","year":"2017","journal-title":"Cell Oncol (Dordr)"},{"key":"10.1016\/j.arcmed.2024.103124_bib0018","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/9513037","article-title":"miR-155 as a biomarker in B-Cell malignancies","volume":"2016","author":"Due","year":"2016","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.arcmed.2024.103124_bib0019","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1158\/1078-0432.CCR-20-3139","article-title":"Cobomarsen, an oligonucleotide inhibitor of miR-155, slows DLBCL tumor cell growth in vitro and in vivo","volume":"27","author":"Anastasiadou","year":"2021","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.arcmed.2024.103124_bib0020","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.bbadis.2011.02.002","article-title":"MicroRNAs and the cell cycle","volume":"1812","author":"Bueno","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.arcmed.2024.103124_bib0021","doi-asserted-by":"crossref","first-page":"13036","DOI":"10.18632\/oncotarget.24437","article-title":"Hsa-miR-155-5p drives aneuploidy at early stages of cellular transformation","volume":"9","author":"Pagotto","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.arcmed.2024.103124_bib0022","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1423-0127-20-79","article-title":"MiR-155 promotes proliferation of human breast cancer MCF-7 cells through targeting tumor protein 53-induced nuclear protein 1","volume":"20","author":"Zhang","year":"2013","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.arcmed.2024.103124_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2021.153405","article-title":"MicroRNA-155-5p promotes tumor progression and contributes to paclitaxel resistance via TP53INP1 in human breast cancer","volume":"220","author":"Li","year":"2021","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.arcmed.2024.103124_bib0024","doi-asserted-by":"crossref","first-page":"D222","DOI":"10.1093\/nar\/gkab1079","article-title":"miRTarBase update 2022: an informative resource for experimentally validated miRNA-target interactions","volume":"50","author":"Huang","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.arcmed.2024.103124_bib0025","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1126\/science.288.5470.1439","article-title":"Regulation of B lymphocyte and macrophage development by graded expression of PU.1","volume":"288","author":"DeKoter","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.arcmed.2024.103124_bib0026","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1084\/jem.20140338","article-title":"The miR-155-PU.1 axis acts on Pax5 to enable efficient terminal B cell differentiation","volume":"211","author":"Lu","year":"2014","journal-title":"J Exp Med"},{"key":"10.1016\/j.arcmed.2024.103124_bib0027","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1182\/blood-2010-05-285064","article-title":"MYB transcriptionally regulates the miR-155 host gene in chronic lymphocytic leukemia","volume":"117","author":"Vargova","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.arcmed.2024.103124_bib0028","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s12185-015-1847-4","article-title":"Oncogenic microRNA-155 and its target PU.1: an integrative gene expression study in six of the most prevalent lymphomas","volume":"102","author":"Huskova","year":"2015","journal-title":"Int J Hematol"},{"key":"10.1016\/j.arcmed.2024.103124_bib0029","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.673286","article-title":"Nanoparticle delivery of CRISPR\/Cas9 for genome editing","volume":"12","author":"Duan","year":"2021","journal-title":"Front Genet"},{"key":"10.1016\/j.arcmed.2024.103124_bib0030","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s12943-021-01431-6","article-title":"Application of the CRISPR\/Cas9-based gene editing technique in basic research, diagnosis, and therapy of cancer","volume":"20","author":"Zhang","year":"2021","journal-title":"Mol Cancer"},{"key":"10.1016\/j.arcmed.2024.103124_bib0031","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153689","article-title":"Genome-wide CRISPR-Cas9 screen identifies MicroRNAs that regulate myeloid leukemia cell growth","volume":"11","author":"Wallace","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.arcmed.2024.103124_bib0032","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/326042","article-title":"CRISPR\/CAS9-mediated genome editing of miRNA-155 inhibits proinflammatory cytokine production by RAW264.7 cells","volume":"2015","author":"Jing","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.arcmed.2024.103124_bib0033","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.arcmed.2024.103124_bib0034","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1093\/bioinformatics\/btac166","article-title":"Analysing high-throughput sequencing data in Python with HTSeq 2.0","volume":"38","author":"Putri","year":"2022","journal-title":"Bioinformatics"},{"key":"10.1016\/j.arcmed.2024.103124_bib0035","first-page":"1438","article-title":"From reads to genes to pathways: differential expression analysis of RNA-Seq experiments using Rsubread and the edgeR quasi-likelihood pipeline","volume":"5","author":"Chen","year":"2016","journal-title":"F1000Res"},{"key":"10.1016\/j.arcmed.2024.103124_bib0036","first-page":"060012","article-title":"Fast gene set enrichment analysis 2016","volume":"10","author":"Korotkevich","year":"2016"},{"key":"10.1016\/j.arcmed.2024.103124_bib0037","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nprot.2009.21","article-title":"Multiplex peptide stable isotope dimethyl labeling for quantitative proteomics","volume":"4","author":"Boersema","year":"2009","journal-title":"Nat Protoc"},{"key":"10.1016\/j.arcmed.2024.103124_bib0038","doi-asserted-by":"crossref","first-page":"e29904","DOI":"10.4161\/mco.29904","article-title":"Chromosomal rearrangements in cancer: detection and potential causal mechanisms","volume":"1","author":"Hasty","year":"2014","journal-title":"Mol Cell Oncol"},{"key":"10.1016\/j.arcmed.2024.103124_bib0039","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1016\/j.celrep.2019.10.097","article-title":"IRF4 activity is required in established plasma cells to regulate gene transcription and mitochondrial homeostasis","volume":"29","author":"Low","year":"2019","journal-title":"Cell Rep"},{"key":"10.1016\/j.arcmed.2024.103124_bib0040","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.3390\/ijms23073469","article-title":"MicroRNAs in leukemias: a clinically annotated compendium","volume":"23","author":"Turk","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.arcmed.2024.103124_bib0041","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1002\/ijc.32894","article-title":"Serum levels of hsa-miR-16-5p, hsa-miR-29a-3p, hsa-miR-150-5p, hsa-miR-155-5p and hsa-miR-223-3p and subsequent risk of chronic lymphocytic leukemia in the EPIC study","volume":"147","author":"Casabonne","year":"2020","journal-title":"Int J Cancer"},{"key":"10.1016\/j.arcmed.2024.103124_bib0042","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/2046545","article-title":"MicroRNA-155-5p overexpression in peripheral blood mononuclear cells of chronic lymphocytic leukemia patients is a novel, independent molecular biomarker of poor prognosis","volume":"2017","author":"Papageorgiou","year":"2017","journal-title":"Dis Markers"},{"key":"10.1016\/j.arcmed.2024.103124_bib0043","doi-asserted-by":"crossref","first-page":"654","DOI":"10.7150\/jca.28537","article-title":"Prognostic and clinicopathological significance of MiR-155 in hematologic malignancies: a systematic review and meta-analysis","volume":"10","author":"Tang","year":"2019","journal-title":"J Cancer"},{"key":"10.1016\/j.arcmed.2024.103124_bib0044","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/carcin\/bgz183","article-title":"miR-155 as a novel clinical target for hematological malignancies","volume":"41","author":"Witten","year":"2020","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.arcmed.2024.103124_bib0045","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1182\/blood-2012-02-410647","article-title":"LNA-mediated anti-miR-155 silencing in low-grade B-cell lymphomas","volume":"120","author":"Zhang","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.arcmed.2024.103124_bib0046","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1021\/acs.molpharmaceut.8b01247","article-title":"Cyclic peptidomimetics as inhibitor for miR-155 biogenesis","volume":"16","author":"Yan","year":"2019","journal-title":"Mol Pharm"},{"key":"10.1016\/j.arcmed.2024.103124_bib0047","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1146\/annurev-biophys-062215-010822","article-title":"CRISPR-Cas9 Structures and Mechanisms","volume":"46","author":"Jiang","year":"2017","journal-title":"Annu Rev Biophys"},{"key":"10.1016\/j.arcmed.2024.103124_bib0048","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41392-023-01309-7","article-title":"CRISPR\/Cas9 therapeutics: progress and prospects","volume":"8","author":"Li","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.arcmed.2024.103124_bib0049","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3390\/cancers11040575","article-title":"HNRNPL restrains miR-155 targeting of BUB1 to stabilize aberrant karyotypes of transformed cells in chronic lymphocytic leukemia","volume":"11","author":"Pagotto","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.arcmed.2024.103124_bib0050","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.02510-22","article-title":"MIR155HG plays a bivalent role in regulating innate antiviral immunity by encoding long noncoding RNA-155 and microRNA-155-5p","volume":"13","author":"Rai","year":"2022","journal-title":"MBio"},{"key":"10.1016\/j.arcmed.2024.103124_bib0051","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1080\/16078454.2020.1860187","article-title":"Up-regulated miR-155 is associated with poor prognosis in childhood acute lymphoblastic leukemia and promotes cell proliferation targeting ZNF238","volume":"26","author":"Liang","year":"2021","journal-title":"Hematology"},{"key":"10.1016\/j.arcmed.2024.103124_bib0052","first-page":"4053","article-title":"MicroRNA-155 regulates the proliferation, cell cycle, apoptosis and migration of colon cancer cells and targets CBL","volume":"14","author":"Yu","year":"2017","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.arcmed.2024.103124_bib0053","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.3390\/cells11040704","article-title":"Journey through time on the discovery of cell cycle regulation","volume":"11","author":"Uzbekov","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.arcmed.2024.103124_bib0054","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1182\/blood.2020008276","article-title":"B-cell receptor signaling and genetic lesions in TP53 and CDKN2A\/CDKN2B cooperate in Richter transformation","volume":"138","author":"Chakraborty","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.arcmed.2024.103124_bib0055","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3389\/fgene.2013.00080","article-title":"Tumor protein 53-induced nuclear protein 1 enhances p53 function and represses tumorigenesis","volume":"4","author":"Shahbazi","year":"2013","journal-title":"Front Genet"},{"key":"10.1016\/j.arcmed.2024.103124_bib0056","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/s41418-022-00988-z","article-title":"Cell cycle regulation: p53-p21-RB signaling","volume":"29","author":"Engeland","year":"2022","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.arcmed.2024.103124_bib0057","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1158\/1541-7786.MCR-15-0399","article-title":"miR-155 overexpression promotes genomic instability by reducing high-fidelity polymerase delta expression and activating error-prone DSB repair","volume":"14","author":"Czochor","year":"2016","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.arcmed.2024.103124_bib0058","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/s41591-018-0049-z","article-title":"CRISPR-Cas9 genome editing induces a p53-mediated DNA damage response","volume":"24","author":"Haapaniemi","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.arcmed.2024.103124_bib0059","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1186\/s12864-018-4556-6","article-title":"The deregulated microRNAome contributes to the cellular response to aneuploidy","volume":"19","author":"D\u00fcrrbaum","year":"2018","journal-title":"BMC Genomics"},{"key":"10.1016\/j.arcmed.2024.103124_bib0060","first-page":"4401","article-title":"Sustained expression of miR-26a promotes chromosomal instability and tumorigenesis through regulation of CHFR","volume":"45","author":"Castellano","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.arcmed.2024.103124_bib0061","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/path.2860","article-title":"Overexpression of miR-210, a downstream target of HIF1\u03b1, causes centrosome amplification in renal carcinoma cells","volume":"224","author":"Nakada","year":"2011","journal-title":"J Pathol"},{"key":"10.1016\/j.arcmed.2024.103124_bib0062","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1158\/0008-5472.CAN-13-2041","article-title":"miR-28-5p promotes chromosomal instability in VHL-associated cancers by inhibiting Mad2 translation","volume":"74","author":"Hell","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.arcmed.2024.103124_bib0063","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/s41590-018-0208-x","article-title":"The effect of cellular context on miR-155-mediated gene regulation in four major immune cell types","volume":"19","author":"Hsin","year":"2018","journal-title":"Nat Immunol"},{"key":"10.1016\/j.arcmed.2024.103124_bib0064","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/imm.12468","article-title":"Physiological roles of miR-155","volume":"145","author":"Mashima","year":"2015","journal-title":"Immunology"},{"key":"10.1016\/j.arcmed.2024.103124_bib0065","first-page":"569","article-title":"CD21 and FCRL5 form a receptor complex with robust B-cell activating capacity","volume":"30","author":"Franco","year":"2018","journal-title":"Int Immunol"},{"key":"10.1016\/j.arcmed.2024.103124_bib0066","doi-asserted-by":"crossref","first-page":"9770","DOI":"10.1073\/pnas.0703354104","article-title":"Fc receptor-like 5 inhibits B cell activation via SHP-1 tyrosine phosphatase recruitment","volume":"104","author":"Haga","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.arcmed.2024.103124_bib0067","doi-asserted-by":"crossref","first-page":"7539","DOI":"10.1093\/nar\/gku465","article-title":"Cooperative gene regulation by microRNA pairs and their identification using a computational workflow","volume":"42","author":"Schmitz","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.arcmed.2024.103124_bib0068","doi-asserted-by":"crossref","first-page":"7753","DOI":"10.1093\/nar\/gkz638","article-title":"Systems biology-based investigation of cooperating microRNAs as monotherapy or adjuvant therapy in cancer","volume":"47","author":"Lai","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.arcmed.2024.103124_bib0069","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109754","article-title":"MicroRNA-1251-5p promotes tumor growth and metastasis of hepatocellular carcinoma by targeting AKAP12","volume":"122","author":"Han","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.arcmed.2024.103124_bib0070","doi-asserted-by":"crossref","first-page":"e34150","DOI":"10.1371\/journal.pone.0034150","article-title":"Differential expression of miRNAs in colorectal cancer: comparison of paired tumor tissue and adjacent normal mucosa using high-throughput sequencing","volume":"7","author":"Hamfjord","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.arcmed.2024.103124_bib0071","doi-asserted-by":"crossref","first-page":"810","DOI":"10.3390\/cells9040810","article-title":"Implication of the p53-Related miR-34c, -125b, and -203 in the osteoblastic differentiation and the malignant transformation of bone sarcomas","volume":"9","author":"Jacques","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.arcmed.2024.103124_bib0072","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/1471-2407-9-194","article-title":"Systematic validation of predicted microRNAs for cyclin D1","volume":"9","author":"Jiang","year":"2009","journal-title":"BMC Cancer"},{"key":"10.1016\/j.arcmed.2024.103124_bib0073","doi-asserted-by":"crossref","first-page":"226","DOI":"10.4161\/cbt.72","article-title":"Cycling to cancer with cyclin D1","volume":"1","author":"Diehl","year":"2002","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.arcmed.2024.103124_bib0074","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1309\/AJCPIVKZRMPF93ET","article-title":"Chronic lymphocytic leukemia\/small lymphocytic lymphoma with cyclin D1 positive proliferation centers do not have CCND1 translocations or gains and lack SOX11 expression","volume":"138","author":"Gradowski","year":"2012","journal-title":"Am J Clin Pathol"}],"container-title":["Archives of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440924001759?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440924001759?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T04:29:23Z","timestamp":1777523363000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0188440924001759"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":74,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S0188440924001759"],"URL":"https:\/\/doi.org\/10.1016\/j.arcmed.2024.103124","relation":{},"ISSN":["0188-4409"],"issn-type":[{"value":"0188-4409","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deficiency of miR-155 in Leukemic B-Cells Results in Cell Cycle Arrest and Deregulation of MIR155HG\/TP53INP1\/CDKN1A\/CCND1 network","name":"articletitle","label":"Article Title"},{"value":"Archives of Medical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcmed.2024.103124","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of Instituto Mexicano del Seguro Social (IMSS).","name":"copyright","label":"Copyright"}],"article-number":"103124"}}